43 In the index
Rasagiline RASA
An FDA-approved medication for Parkinson's disease, used alone in early stages or combined with other Parkinson's drugs. Human studies confirm real symptom relief and hint at possibly slowing the disease itself, with a generally well-tolerated profile.
Also known as Azilect
3D Molecular Structure of C12H13N
Drag to rotate · scroll to zoom
Chemistry
- Formula
- C12H13N
- Molar mass
- 171.24
- CAS
- 136236-51-6
- PubChem CID
- 3052776
Reported dosing
Approved labelWhat has been reported in the literature and by users. This is a record of what is done, not a recommendation.
Typical dose
0.5-1 mg/day
Reported range
0.5-1 mg/day
Route
Oral
Frequency
Once daily
Duration
Chronic/ongoing (as prescribed)
FDA-approved MAO-B inhibitor (Azilect) for Parkinson's disease; requires dietary tyramine precautions at higher doses.
Where this comes from
FDA prescribing information
These figures are recorded for reference and are not a recommendation. Dosing is a decision for you and a clinician.